News

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...
A dad who thought he had a UTI was diagnosed with stage four bladder cancer and given 24 months to live. Dad-of-two Chris Cotton, 50, started experiencing what he believed were UTI symptoms in ...
Patterson-UTI Energy PTEN is preparing to release its quarterly earnings on Wednesday, 2025-04-23. Here's a brief overview of what investors should keep in mind before the announcement.
Having sex is a common cause of urinary tract infections (UTIs), especially for women. Preventative steps like peeing after sex and drinking lots of water may help. A urinary tract infection (UTI ...
Using blue light to fight drug-resistant infections Date: April 22, 2025 Source: University of Oklahoma Summary: Researchers have made a breakthrough discovery that could potentially revolutionize ...
Biofilms are found in numerous difficult-to-treat infections such as chronic wounds, urinary tract infections, cystic fibrosis-related lung infections, and even acne. The team are now working to ...
The presence of nitrites and/or leukocyte esterase in urine has good overall sensitivity (46–100%) and specificity (42–98%) for culture-proven urinary tract infection. Empiric treatment in ...
The UTI Flexi Cap Fund Regular Plan Growth has an AUM of 24531.52 crores & has delivered CAGR of 20.52% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.67%.
The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.